AngioDynamics, Inc.
ANGOHealthcareNASDAQMedical Instruments & Supplies · Last scanned May 30, 2026
Scan Results
Daily timeframePart of the healthcare sector, AngioDynamics, Inc. (ANGO) is listed under Medical Instruments & Supplies. The $474.3M market capitalization puts ANGO squarely in small-cap range for its industry. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.
Market Cap
$474.3M
Beta
0.37
P/E (TTM)
—
P/E (Fwd)
-52.18
EPS (TTM)
$-0.76
EPS (Fwd)
$-0.22
ROE
-17.5%
ROA
-4.7%
Cash
$37.8M
Total Debt
$11.4M
Free CF
$13.9M
52W Change
18.4%
Annual Financials
Cash vs Debt
With $37.8M in cash and $11.4M in debt, ANGO maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $13.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -17.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $316.2M (2022) to $292.5M (2025).
With a beta below 0.7, AngioDynamics, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for AngioDynamics, Inc. and its sector.